Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction

Hypertension

Volumn 35, Issue 3, 2000, Pages 704-709

  Hengstenberg, Christian ^a   Holmer, Stephan R ^a   Mayer, Björn ^a   Löwel, Hannelore ^b   Engel, Susanne ^b   Hense, Hans Werner ^c   Riegger, Günter A J ^a   Schunkert, Heribert ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aldosterone; Cardiac function; Echocardiography; Genes; Myocardial infarction

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE;

ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0034023169     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.704     Document Type: Article

References (20)

1. Rouleau JL, Packer M, Moye L, de Champlain J, Bichet D, Klein M, Rouleau JR, Sussex B, Arnold JM, Sestier F. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol. 1994;24:583-591.
2. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med. 1994;331:250-258.
3. Weber KT, Sun Y, Campbell SE, Slight SH, Ganjam VK, Griffing GT, Swinfard RW, Diaz-Arias AA. Chronic mineralocorticoid excess and cardiovascular remodeling. Steroids. 1995;60:125-132.
4. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation. 1998;97:569-575.
5. Tamaki S, Iwai N, Tsujita Y, Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension. 1999;33: 266-270.
6. Schunkert H, Hengstenberg C, Holmer SR, Broeckel U, Luchner A, Muscholl MW, Kürzinger S, Döring A, Hense HW, Riegger GAJ. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation. 1999;99:2255-2260.
7. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, Corvol P, Pascoe L, Soubrier F. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32: 198-204.
8. Duprez DA, Bauwens FR, De Buyzere ML, De Backer TL, Kaufman JM, Van Hoecke J, Vermeulen A, Clement DL. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol. 1993;71:17A-20A.
9. Navarro-Lopez F, Coca A, Pare JC, de la Sierra A, Bosch X, Urbano Marquez A. Left ventricular hypertrophy in asymptomatic essential hypertension: its relationship with aldosterone and the increase in sodium-proton exchanger activity. Eur Heart J. 1993;14(suppl J):38-41.
10. Muscholl M, Schunkert H, Muders F, Elsner D, Kuch B, Hense HW, Riegger GAJ. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J. 1998;135: 58-66.
11. Löwel H, Lewis M, Hörmann A, Keil U. Case finding, data quality aspects, and comparability of myocardial infarction registers: results of a Southern German register study. J Clin Epidemiol. 1991;44:249-260.
12. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
13. Muscholl M, Hense HW, Bröcket U, Döring A, Riegger GAJ, Schunkert H. Alterations of left ventricular geometry and function in subjects with white coat hypertension. BMJ. 1998;317:565-570.
14. Schunkert H, Hense HW, Danser J, Muscholl M, Luchner A, Riegger AJG. Association between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart. 1997;77:24-31.
15. Devereux RB, Reicek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutfesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. Recommendations for the quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
17. Cavalli-Sforza LL, Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet. 1993;1:3-18.
18. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens. 1998;11:856-860.
19. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JMC. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension. 1999; 33:703-707.
20. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill JR Jr, Feld L, Ganguly A, Laidlaw JC, Murnagham DJ, Kaufman C, Stockigt JR, Ulrick C, Lalouel JM. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet. 1992;2:66-74.